EU Tenders

Antivirals for systemic use tenders in Belgium

CPV 33651400-2 · part of 33000000 Medical equipments, pharmaceuticals and personal care products › 33600000 Pharmaceutical products › 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents › 33651000 General anti-infectives for systemic use and vaccines

4 notices for CPV 33651400 Antivirals for systemic use in Belgium on TED since 29 May 2026: 3 calls for competition and 1 contract award. 0 of these tenders are open today.

Top buyers

BuyerNotices
HUmani SC2
Hospilim VZW2

Top winners

WinnerAwards
Prothya Biosolutions Netherlands B.V.1

All notices

Raamovereenkomst voor voor het leveren van polyvalente humane immunoglobulinen, protrombinecomplexconcentraat en fibrinogeen
Award · Immune sera and immunoglobulins · 4 Nov 2026 · Belgium · Hospilim VZW · value EUR 36,801,000 · won by Prothya Biosolutions Netherlands B.V.
ANTI-INFECTIEUX 2026-2030
Tender · Antibacterials for systemic use · 12 Jun 2026 · Belgium · HUmani SC · closed 14 Jul 2026
ANTI-INFECTIEUX 2026-2030
Tender · Antibacterials for systemic use · 2 Jun 2026 · Belgium · HUmani SC · closed 30 Jun 2026
Raamovereenkomst voor voor het leveren van polyvalente humane immunoglobulinen, protrombinecomplexconcentraat en fibrinogeen
Tender · Immune sera and immunoglobulins · 29 May 2026 · Belgium · Hospilim VZW · closed 29 Jun 2026

Questions

How many antivirals for systemic use tenders are open in Belgium?

0 calls for competition under CPV 33651400 are open on 22 Nov 2026, out of 3 published since 29 May 2026.

Who buys the most antivirals for systemic use in Belgium?

HUmani SC leads with 2 notices under CPV 33651400.

Which company wins the most antivirals for systemic use contracts in Belgium?

Prothya Biosolutions Netherlands B.V. appears in 1 award notice under CPV 33651400.

Get new antivirals for systemic use tenders by email

A free weekly digest of new competition notices from TED. One-click unsubscribe in every email.

A manager will help with your first launch.